Federated Hermes Portfolio holdings
Federated Hermes is an investment manager that runs mutual funds, ETFs and other portfolios across stocks, bonds, alternative and private markets and liquidity management. It began in 1955 as Federated Investors, set up by three high school classmates: John F. Donahue, Thomas J. Donnelly and Richard B. Fisher. In 2018 the firm bought a majority stake in Hermes Fund Managers, which ran Hermes Investment Management, from the BT Pension Scheme. In 2020 Federated Investors renamed itself Federated Hermes. Its clients include corporations, government entities, insurance companies, foundations, endowments, banks and brokerages.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$436M |
| 2 |
Regions Financial
RF
|
+$313M |
| 3 |
Automatic Data Processing
ADP
|
+$289M |
| 4 |
Intuit
INTU
|
+$288M |
| 5 |
Netflix
NFLX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 2 |
Teradyne
TER
|
+$320M |
| 3 |
Truist Financial
TFC
|
+$313M |
| 4 |
UnitedHealth
UNH
|
+$287M |
| 5 |
Huntington Bancshares
HBAN
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.03% |
| 2 | Healthcare | 13.59% |
| 3 | Industrials | 13.09% |
| 4 | Financials | 10.33% |
| 5 | Consumer Discretionary | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1076
Axalta
AXTA
$7.29B
| $1.39M | ﹤0.01% |
40,686
-6,379
| -14% | -$192K |
2017 Q2
36 quarters
|
|
1077
Aurinia Pharmaceuticals
AUPH
$2.23B
| $1.37M | ﹤0.01% |
80,994
+14,201
| +21% | +$227K |
2024 Q1
9 quarters
|
|
1078
ITT
ITT
$17.7B
| $1.37M | ﹤0.01% |
6,921
+85
| +1% | +$17.2K |
2013 Q2
52 quarters
|
|
1079
East-West Bancorp
EWBC
$17.9B
| $1.37M | ﹤0.01% |
10,597
-347
| -3% | -$42.6K |
2013 Q2
52 quarters
|
|
1080
PDF Solutions
PDFS
$1.73B
| $1.37M | ﹤0.01% |
19,300
| – | – |
2025 Q4
2 quarters
|
|
1081
QuinStreet
QNST
$996M
| $1.36M | ﹤0.01% |
93,020
-48,749
| -34% | -$612K |
2025 Q3
3 quarters
|
|
1082
Graco
GGG
$10.8B
| $1.36M | ﹤0.01% |
17,998
+10
| +0.1% | +$789 |
2013 Q2
52 quarters
|
|
1083
Performance Food Group
PFGC
$15.6B
| $1.36M | ﹤0.01% |
12,137
-351
| -3% | -$33.4K |
2021 Q3
19 quarters
|
|
1084
Dianthus Therapeutics
DNTH
$4.61B
| $1.35M | ﹤0.01% |
+13,823
| New | +$1.21M |
2026 Q2
0 quarters
|
|
1085
ThredUp
TDUP
$273M
| $1.34M | ﹤0.01% |
196,162
-915,785
| -82% | -$4.28M |
2025 Q2
4 quarters
|
|
1086
First Bancorp
FBNC
$2.63B
| $1.34M | ﹤0.01% |
20,920
-6,339
| -23% | -$375K |
2013 Q4
50 quarters
|
|
1087
DT Midstream
DTM
$12.7B
| $1.33M | ﹤0.01% |
9,038
-804
| -8% | -$114K |
2021 Q3
19 quarters
|
|
1088
Contango Silver & Gold Inc
CTGO
$459M
| $1.32M | ﹤0.01% |
83,507
-204,777
| -71% | -$4.22M |
2025 Q2
4 quarters
|
|
1089
Norwegian Cruise Line
NCLH
$8.07B
| $1.32M | ﹤0.01% |
62,350
+60,441
| +3,166% | +$1.13M |
2023 Q1
13 quarters
|
|
1090
Toll Brothers
TOL
$13.4B
| $1.31M | ﹤0.01% |
7,941
-195
| -2% | -$27.7K |
2013 Q2
52 quarters
|
|
1091
Kinetik
KNTK
$4.55B
| $1.31M | ﹤0.01% |
27,042
-18
| -0.1% | -$860 |
2024 Q2
8 quarters
|
|
1092
Futu Holdings
FUTU
$13.8B
| $1.3M | ﹤0.01% |
13,880
+1,133
| +9% | +$145K |
2024 Q1
9 quarters
|
|
1093
Neogen
NEOG
$2.58B
| $1.29M | ﹤0.01% |
143,897
-1,454,105
| -91% | -$13.3M |
2025 Q2
4 quarters
|
|
1094
Brink's
BCO
$4.23B
| $1.28M | ﹤0.01% |
13,577
-385
| -3% | -$40.1K |
2017 Q2
36 quarters
|
|
1095
Gogo Inc
GOGO
$320M
| $1.27M | ﹤0.01% |
411,092
+410,746
| +118,713% | +$1.67M |
2025 Q3
3 quarters
|
|
1096
BorgWarner
BWA
$10.4B
| $1.27M | ﹤0.01% |
19,176
-1,047
| -5% | -$66.3K |
2013 Q2
52 quarters
|
|
1097
Thryv Holdings
THRY
$55.5M
| $1.27M | ﹤0.01% |
322,986
-932
| -0.3% | -$3.31K |
2025 Q4
2 quarters
|
|
1098
Under Armour
UAA
$2.14B
| $1.26M | ﹤0.01% |
197,499
-1
| -0% | -$6 |
2013 Q2
52 quarters
|
|
1099
Heritage Financial
HFWA
$1.16B
| $1.25M | ﹤0.01% |
42,298
+802
| +2% | +$22.1K |
2022 Q4
14 quarters
|
|
1100
Bio-Rad Laboratories Class A
BIO
$10B
| $1.25M | ﹤0.01% |
4,258
-105,637
| -96% | -$30M |
2013 Q2
52 quarters
|
|
Similar funds
Federated Hermes's Q2 2026 Portfolio in Review
As of Q2 2026, Federated Hermes held 2,221 positions worth $69.6B, up 13% from $61.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2026 filing shows 173 new, 863 increased, 913 reduced and 183 closed positions. Its largest new stake was AngloGold Ashanti: 2,040,755 shares worth $165M. The largest sale was Alphabet (Google) Class A, an estimated $390M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- Federated Hermes's largest Q2 2026 buy was AngloGold Ashanti: 2,040,755 shares worth $165M.
- Federated Hermes added most to Apple in Q2 2026, an estimated $436M increase.
- Federated Hermes's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $390M.
- Federated Hermes fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $81.4M.
- Federated Hermes's ten largest holdings make up 16% of its $69.6B portfolio in Q2 2026.
- Federated Hermes opened 173 new positions and closed 183 in Q2 2026.
- Federated Hermes's portfolio value rose 13% quarter-over-quarter to $69.6B.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.